These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 37424279

  • 1. 18 F-FDG PET/CT predicts the role of neoadjuvant immunochemotherapy in the pathological response of esophageal squamous cell carcinoma.
    Wang S, Di S, Lu J, Xie S, Yu Z, Liang Y, Gong T.
    Thorac Cancer; 2023 Aug; 14(24):2338-2349. PubMed ID: 37424279
    [Abstract] [Full Text] [Related]

  • 2. Diffusion-weighted MRI and 18F-FDG PET/CT in assessing the response to neoadjuvant chemoradiotherapy in locally advanced esophageal squamous cell carcinoma.
    Xu X, Sun ZY, Wu HW, Zhang CP, Hu B, Rong L, Chen HY, Xie HY, Wang YM, Lin HP, Bai YR, Ye Q, Ma XM.
    Radiat Oncol; 2021 Jul 19; 16(1):132. PubMed ID: 34281566
    [Abstract] [Full Text] [Related]

  • 3. The role of 18F-FDG PET/CT in predicting the pathological response to neoadjuvant PD-1 blockade in combination with chemotherapy for resectable esophageal squamous cell carcinoma.
    Wang X, Yang W, Zhou Q, Luo H, Chen W, Yeung SJ, Zhang S, Gan Y, Zeng B, Liu Z, Feng S, Zhang X, Cheng C.
    Eur J Nucl Med Mol Imaging; 2022 Oct 19; 49(12):4241-4251. PubMed ID: 35732974
    [Abstract] [Full Text] [Related]

  • 4. Combining the radiomic features and traditional parameters of 18F-FDG PET with clinical profiles to improve prognostic stratification in patients with esophageal squamous cell carcinoma treated with neoadjuvant chemoradiotherapy and surgery.
    Chen YH, Lue KH, Chu SC, Chang BS, Wang LY, Liu DW, Liu SH, Chao YK, Chan SC.
    Ann Nucl Med; 2019 Sep 19; 33(9):657-670. PubMed ID: 31218571
    [Abstract] [Full Text] [Related]

  • 5. Use of 18F Fluorodeoxyglucose Positron Emission Tomography Computed Tomography in Assessing Response to Neoadjuvant Chemoradiation and Its Impact on Survival in Esophageal Squamous Cell Carcinoma.
    Iqbal SA, Goel S, Aggarwal A, Gupta N, Gupta M, Durga G, Talwar V, Singh S.
    J Gastrointest Cancer; 2021 Sep 19; 52(3):1073-1080. PubMed ID: 33128717
    [Abstract] [Full Text] [Related]

  • 6. The utility of 18F-FDG PET/CT for predicting the pathological response and prognosis to neoadjuvant immunochemotherapy in resectable non-small-cell lung cancer.
    Guo R, Yan W, Wang F, Su H, Meng X, Xie Q, Zhao W, Yang Z, Li N.
    Cancer Imaging; 2024 Sep 10; 24(1):120. PubMed ID: 39256860
    [Abstract] [Full Text] [Related]

  • 7. Pathologic responses and surgical outcomes after neoadjuvant immunochemotherapy versus neoadjuvant chemoradiotherapy in patients with locally advanced esophageal squamous cell carcinoma.
    Xu L, Wei XF, Li CJ, Yang ZY, Yu YK, Li HM, Xie HN, Yang YF, Jing WW, Wang Z, Kang XZ, Zhang RX, Qin JJ, Xue LY, Bi N, Chen XK, Li Y.
    Front Immunol; 2022 Sep 10; 13():1052542. PubMed ID: 36466925
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The predictive value of 18F-FDG PET/CT combined with inflammatory index for major pathological reactions in resectable NSCLC receiving neoadjuvant immunochemotherapy.
    Yin X, Li J, Chen B, Liu K, Hu S.
    Lung Cancer; 2023 Dec 10; 186():107389. PubMed ID: 37820538
    [Abstract] [Full Text] [Related]

  • 16. Determinants of response to neoadjuvant chemotherapy for esophageal cancer using 18F-fluorodeoxiglucose positron emission tomography (18F-FDG-PET).
    Miyata H, Yamasaki M, Takahashi T, Murakami K, Tanaka K, Yukinori K, Nakajima K, Takiguchi S, Morii E, Hatazawa J, Mori M, Doki Y.
    Ann Surg Oncol; 2014 Feb 10; 21(2):575-82. PubMed ID: 24201746
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Complete pathological response (pCR) in gastroesophageal cancer: Correlation with metabolic response.
    Cabral F, Cruz A, Casaca R, Monteiro C, Ramos P, Pedro C, Brandão F, Fonseca R, Ratão P, Salgado L, Pinto I, Abecasis N.
    Cancer Radiother; 2020 Dec 10; 24(8):834-841. PubMed ID: 33191120
    [Abstract] [Full Text] [Related]

  • 19. Dynamic radiological features predict pathological response after neoadjuvant immunochemotherapy in esophageal squamous cell carcinoma.
    Ruan Y, Ma Y, Ma M, Liu C, Su D, Guan X, Yang R, Wang H, Li T, Zhou Y, Ma J, Zhang Y.
    J Transl Med; 2024 May 18; 22(1):471. PubMed ID: 38762454
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.